Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment ; volume:13 ; number:1 ; year:2019 ; pages:37-49
Case reports in gastroenterology ; 13, Heft 1 (2019), 37-49
- Creator
-
Suzuki, Taketo
Mizoshita, Tsutomu
Sugiyama, Tomoya
Hirata, Yoshikazu
Kimura, Yoshihide
Suzuki, Yuka
Yamada, Tomonori
Tsukamoto, Hironobu
Mizushima, Takashi
Sugimura, Naomi
Katano, Takahito
Tanida, Satoshi
Kataoka, Hiromi
Sasaki, Makoto
- DOI
-
10.1159/000496453
- URN
-
urn:nbn:de:101:1-2019051601014121925818
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suzuki, Taketo
- Mizoshita, Tsutomu
- Sugiyama, Tomoya
- Hirata, Yoshikazu
- Kimura, Yoshihide
- Suzuki, Yuka
- Yamada, Tomonori
- Tsukamoto, Hironobu
- Mizushima, Takashi
- Sugimura, Naomi
- Katano, Takahito
- Tanida, Satoshi
- Kataoka, Hiromi
- Sasaki, Makoto
Other Objects (12)
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Untersuchungen zum Krankheitsverlauf von Patienten mit Morbus Crohn unter der Therapie mit Adalimumab
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Untersuchungen zum Krankheitsverlauf von Patienten mit Morbus Crohn unter der Therapie mit Adalimumab
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies